Olive S. Eckstein

1.7k total citations
29 papers, 411 citations indexed

About

Olive S. Eckstein is a scholar working on Physiology, Surgery and Immunology. According to data from OpenAlex, Olive S. Eckstein has authored 29 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 8 papers in Surgery and 8 papers in Immunology. Recurrent topics in Olive S. Eckstein's work include Histiocytic Disorders and Treatments (16 papers), Parvovirus B19 Infection Studies (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Olive S. Eckstein is often cited by papers focused on Histiocytic Disorders and Treatments (16 papers), Parvovirus B19 Infection Studies (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). Olive S. Eckstein collaborates with scholars based in United States, Canada and United Kingdom. Olive S. Eckstein's co-authors include Carl E. Allen, Kenneth L. McClain, Michael B. Jordan, Stephan Ladisch, Kim E. Nichols, Jay Greenberg, M M Henry, Ashish Kumar, Carlos Rodríguez‐Galindo and Birte Wistinghausen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Olive S. Eckstein

26 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olive S. Eckstein United States 9 242 175 162 112 65 29 411
Hongyun Lian China 10 177 0.7× 142 0.8× 150 0.9× 97 0.9× 76 1.2× 50 330
Jan Zernicke Germany 10 161 0.7× 56 0.3× 158 1.0× 46 0.4× 57 0.9× 18 602
Young Tak Lim South Korea 13 174 0.7× 67 0.4× 98 0.6× 24 0.2× 88 1.4× 43 412
Deepak Chellapandian United States 9 210 0.9× 176 1.0× 189 1.2× 33 0.3× 42 0.6× 22 378
Prasad Rao Koduri United States 14 260 1.1× 220 1.3× 85 0.5× 40 0.4× 25 0.4× 27 491
M C Putti Italy 6 287 1.2× 149 0.9× 289 1.8× 14 0.1× 41 0.6× 6 481
Eleonor Tiblad Sweden 18 326 1.3× 171 1.0× 173 1.1× 69 0.6× 88 1.4× 44 803
Gaurav Kharya India 10 109 0.5× 64 0.4× 34 0.2× 41 0.4× 35 0.5× 31 266
Ömer Devecioğlu Türkiye 14 164 0.7× 66 0.4× 48 0.3× 20 0.2× 66 1.0× 59 482

Countries citing papers authored by Olive S. Eckstein

Since Specialization
Citations

This map shows the geographic impact of Olive S. Eckstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olive S. Eckstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olive S. Eckstein more than expected).

Fields of papers citing papers by Olive S. Eckstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olive S. Eckstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olive S. Eckstein. The network helps show where Olive S. Eckstein may publish in the future.

Co-authorship network of co-authors of Olive S. Eckstein

This figure shows the co-authorship network connecting the top 25 collaborators of Olive S. Eckstein. A scholar is included among the top collaborators of Olive S. Eckstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olive S. Eckstein. Olive S. Eckstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Lin, Howard, Akanksha Batajoo, Harshal Abhyankar, et al.. (2024). Clinical, radiological and molecular responses to combination chemotherapy with MAPK pathway inhibition in relapsed and refractory Langerhans cell histiocytosis. British Journal of Haematology. 204(5). 1882–1887. 4 indexed citations
3.
Lin, Howard, Kenneth L. McClain, Nitya Gulati, et al.. (2023). Retrospective Analysis of Clofarabine Salvage Therapy in Refractory Multifocal Langerhans Cell Histiocytosis (LCH). Blood. 142(Supplement 1). 4574–4574. 1 indexed citations
4.
El‐Mallawany, Nader Kim, Howard Lin, Harshal Abhyankar, et al.. (2023). Responses to Combination Chemotherapy with MAPK Pathway Inhibition in Relapsed and Refractory LCH. Blood. 142(Supplement 1). 6349–6349.
5.
Burke, Thomas M., Harshal Abhyankar, Brooks Scull, et al.. (2020). Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH. Blood. 137(13). 1777–1791. 28 indexed citations
6.
Naik, Swati, Olive S. Eckstein, Ghadir Sasa, et al.. (2020). Incorporation of thiotepa in a reduced intensity conditioning regimen may improve engraftment after transplant for HLH. British Journal of Haematology. 188(6). e84–e87. 10 indexed citations
7.
Eckstein, Olive S., Jed G. Nuchtern, George B. Mallory, et al.. (2020). Management of severe pulmonary Langerhans cell histiocytosis in children. Pediatric Pulmonology. 55(8). 2074–2081. 8 indexed citations
8.
Bertuch, Alison A., et al.. (2019). Severe therapy‐related toxicities after treatment for Hodgkin lymphoma due to a pathogenic TERT variant and shortened telomeres. Pediatric Blood & Cancer. 66(8). e27779–e27779. 2 indexed citations
9.
Naik, Swati, Olive S. Eckstein, Ghadir Sasa, et al.. (2019). Incorporation of Thiotepa in a Reduced Intensity Conditioning Regimen Leads to Improved Engraftment after Stem Cell Transplant for Patients with Hemophagocytic Lymphohistiocytosis. Blood. 134(Supplement_1). 3273–3273. 1 indexed citations
10.
Zinn, Daniel, et al.. (2019). Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis. PubMed. 4(1). 2 indexed citations
11.
Jordan, Michael B., Carl E. Allen, Jay Greenberg, et al.. (2019). Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO). Pediatric Blood & Cancer. 66(11). e27929–e27929. 215 indexed citations
12.
Vallejo, Jesús G., et al.. (2018). Persistent fever in a pediatric renal transplant patient: Questions. Pediatric Nephrology. 34(5). 823–824. 1 indexed citations
13.
Vallejo, Jesús G., et al.. (2018). Persistent fever in a pediatric renal transplant patient: Answers. Pediatric Nephrology. 34(5). 825–828. 3 indexed citations
14.
Eckstein, Olive S., Daniel Zinn, Carolyn Fein Levy, et al.. (2018). Clinical Outcomes and Molecular Responses in Children with Langerhans Cell Histiocytosis Treated with MAPK Pathway Inhibitors. Blood. 132(Supplement 1). 3684–3684. 2 indexed citations
15.
Chakraborty, Rikhia, Carl E. Allen, Amos Gaikwad, et al.. (2017). Immune Checkpoint Inhibitors Restore Function of Lesion Infiltrating T Lymphocytes in Langerhans Cell Histiocytosis. Blood. 130. 2280–2280. 1 indexed citations
16.
Eckstein, Olive S., Linghua Wang, Steven M. Kornblau, et al.. (2016). Mixed-phenotype acute leukemia (MPAL) exhibits frequent mutations in DNMT3A and activated signaling genes. Experimental Hematology. 44(8). 740–744. 39 indexed citations
17.
Grimes, Amanda B., Daniel Zinn, Olive S. Eckstein, Carl E. Allen, & Kenneth L. McClain. (2015). Hydroxyurea for the Treatment of Relapsed/Refractory Langerhans Cell Histiocytosis. Blood. 126(23). 1624–1624. 1 indexed citations
18.
Eckstein, Olive S., Linghua Wang, Steven M. Kornblau, et al.. (2014). Mixed Phenotype Acute Leukemia (MPAL) Has a High Frequency of Mutations in Epigenetic Regulatory Genes: Results from Whole Exome Sequencing. Blood. 124(21). 3560–3560. 3 indexed citations
19.
Steil, Garry M., et al.. (2011). Non-invasive cardiac output and oxygen delivery measurement in an infant with critical anemia. Journal of Clinical Monitoring and Computing. 25(2). 113–119. 8 indexed citations
20.
Eckstein, Olive S., Anat Stemmer‐Rachamimov, Fabio P. Nunes, et al.. (2004). Multiple meningiomas in brain and lung due to acquired mutation of the NF2 gene. Neurology. 62(10). 1904–1905. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026